BCAT1 and chromophobe renal cell carcinoma: Among these cancers, to the best of our knowledge, our study is the first to shed light on the diverse expression of BCAT1 in CHOL, kidney chromophobe, STAD, and thyroid carcinoma, suggesting the novelty of our research.